LoginRegister
    FDA grants new indication for BRIVIACT for partial-onset seizures in patients 16 years and older with epilepsy.FDA grants new indication for BRIVIACT for partial-onset seizures in patients 16 years and older...
    Zydus Nesher Pharma gets USFDA nod to market influenza drugZydus Nesher Pharma gets USFDA nod to market influenza drug
    CDSCO declares certain blood grouping serums NOT OF STANDARD QUALITYCDSCO declares certain blood grouping serums NOT OF STANDARD QUALITY
    Zydus Cadila gets USFDA nod for two drugsZydus Cadila gets USFDA nod for two drugs
    No mid-term revision of stent prices before February 2018: NPPANo mid-term revision of stent prices before February 2018: NPPA
    Amgen gets FDA approval for Mvasi- first biosimilar to treat cancerAmgen gets FDA approval for Mvasi- first biosimilar to treat cancer
    CDSCO challenges FDC order in Supreme Court, Final hearing on the 19th SeptCDSCO challenges FDC order in Supreme Court, Final hearing on the 19th Sept
    Bayer gets FDA approval for Aliqopa (copanlisib) to treat adults with relapsed follicular lymphomaBayer gets FDA approval for Aliqopa (copanlisib) to treat adults with relapsed follicular lymphoma
    Blockbuster cancer drug Keytruda launched in IndiaBlockbuster cancer drug Keytruda launched in India
    Pharma Bro ordered jailed for online bounty on Hillary Clintons hairPharma Bro ordered jailed for online bounty on Hillary Clintons hair
    Medtronic announces voluntary recall of Diabetes Infusion Sets MiniMed worldwideMedtronic announces voluntary recall of Diabetes Infusion Sets MiniMed worldwide
    Lupins US arm recalls 12,888 bottles of ulcer drug in USLupins US arm recalls 12,888 bottles of ulcer drug in US
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X